Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine-Alcohol Vs. Povidone-Iodine for Prevention of Surgical Site Infection After Cesarean Delivery
NCT02027324Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of chlorhexidine + alcohol in surgical site infection (SSI) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Incidence of Surgical Site Infection at 30 days. Planned start Jun 2015; status: withdrawn.
02
Drugs
chlorhexidine + alcohol
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02027324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027324.